Citations

Clear

6274 citation(s) found for "To, Andrew".

Abstract 13168: Cardiac Magnetic Resonance Imaging in a Phase 2 Study of Rilonacept in Recurrent Pericarditis
Lin, David , Nasir, Saifullah, Ertel, Andrew, Beutler, Anna , Fang, Fang , Paolini, John F. , Cremer, Paul , Luis, Sushil Allen , Klein, Allan L.

Mayo Clinic

Circulation | May 10, 2021 | Volume: 142 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.142.suppl_3.13168 Get It

Introduction: The magnitude of pericardial delayed hyperenhancement (DHE) by cardiac magnetic resonance imaging (CMR) illustrates the severity of inflammation in pericarditis. We report exploratory CMR data from an open-label Phase 2 study of rilonacept (IL-1α/IL-1β inhibitor) in recurrent pericarditis (RP). Methods: Patients (pts) with idiopathic RP or post-pericardiotomy syndrome (PPS) enrolled in the study. A subset had CMR at baseline (BL) and final visit (FV, 6 mo). Pain (NRS) and inflammation (CRP) were also collected. CMR images were graded (none, mild, moderate, or severe DHE) by a central core lab blinded to clinical data. Results: Of 25 study pts, 11 had CMR at BL and FV; 6 active idiopathic RP, and 5 corticosteroid (CS)-dependent non-active RP (4 idiopathic, 1 PPS). At BL, DHE was severe (3), moderate (2), and none (1) in active RP pts and moderate (1) or mild/none (4) in CS-dependent pts (Figure 1). At FV, DHE was improved (2), resolved (2; one pt example in Figure C/D), or unchanged (2) in active RP pts and was improved (1), resolved (1), unchanged (2) or worsened from none to mild (1) in CS-dependent pts. DHE improvements were associated with decreased pain and CRP and occurred despite discontinuation of CS or reduction in dose level. One pt with severe DHE at baseline and mild DHE at FV experienced a recurrence ~8 weeks after rilonacept discontinuation and enrolled a second time with severe DHE; the patient had reduced CRP and pain NRS during both enrollments and ended the second enrollment with moderate DHE. Conclusions: Serial CMR demonstrated improvement in pericardial DHE after 6 mo of rilonacept treatment, consistent with clinical improvement, while corticosteroids were tapered/discontinued. Recurrence in one pt with incompletely resolved DHE after 6 months of rilonacept treatment could indicate that a longer treatment duration is warranted in patients with unresolved DHE. These preliminary results may inform future CMR-guided treatment studies in RP.
Case Report: Opsoclonus-Myoclonus Syndrome Associated With Contactin-Associated Protein-Like 2 and Acetylcholine Receptor Autoantibodies in the Setting of Non-Small Cell Lung Carcinoma
Rosenow, Christian S. , Dawit, Sara, Farrugia, Luca, Henry, Katharine , Sharma, Akanksha , Porter, Alyx B. , Grill, Marie , Farrugia, Luca P, Henry Ma, Katharine A, Grill, Marie F, McKeon, Andrew

Mayo Clinic

The Neurohospitalist | May 9, 2021 | Volume: 12 | Issue: 1 | Pages: 100-104

10.1177/19418744211012899 | PMID 34950395 Get It

Opsoclonus myoclonus syndrome (OMS) is a rare immune-mediated paraneoplastic or para/-post-infectious syndrome characterized by “dancing” eye movements, myoclonus, and ataxia. Neuropsychiatric symptoms have also been reported. Without treatment, OMS may progress to further neurological impairment and even death. Autoimmune attack of CNS structures in OMS is most commonly mediated by anti-Ri (also known as ANNA2) IgG antibodies, with additional findings implicating antibodies targeting various neurotransmitter receptors. Prompt immunotherapy and neoplasm treatment may result in improvement. We report a novel association of Contactin-Associated Protein-Like 2 (Caspr2) antibodies occurring in association with paraneoplastic OMS. While breast cancer and small cell lung cancer (SCLC) are more commonly associated with OMS among adults, we characterize a novel association between Caspr2 antibody in a patient with mixed non-small cell and small cell lung carcinoma.
Survey of the Transcription Factor Responses of Mouse Lung Alveolar Macrophages to Pneumocystis murina
Kottom, Theodore J. , Schaefbauer, Kyle, Carmona, Eva M. , Carmona, Eva M , Kottom, Theodore J , Limper, Andrew H.

Mayo Clinic

Pathogens | May 8, 2021 | Volume: 10 | Issue: 5 | Pages: 569

10.3390/pathogens10050569 | PMID 34066663 Get It

Pneumocystis jirovecii is a fungal pathogen that can cause life-threatening infections in individuals who are immunocompromised. Acquired via inhalation, upon entering the respiratory tract, the fungi first encounter innate immune cells such as alveolar macrophages (AMs). Relatively little is known about the AM cellular responses to the organism, and particularly transcription factor (TF) profiles leading to early host responses during infection. Utilizing the Mouse Transcription Factors RT2 Profiler™ PCR Array, we report an initial TF survey of these macrophage and Pneumocystis interactions. Expression levels of a panel of mouse TFs were compared between unstimulated and Pneumocystis murina-stimulated AMs. Interestingly, a number of TFs previously implicated in pathogen–host cell interactions were highly up- or downregulated, including hif1a and Pparg. qPCR experiments were further conducted to verify the results of these surveyed transcripts. Furthermore, with immunoblotting, we show that HIF-1A and PPAR-γ are indeed significantly upregulated and downregulated, respectively. Lastly, and importantly, we report that in the mouse model of Pneumocystis pneumonia (PCP), which mimics human Pneumocystis jirovecii pneumonia (PJP), qPCR analysis of Pneumocystis murina lungs also mimic the initial TF profile analysis, suggesting an importance for these TFs in immunocompromised hosts with Pneumocystis pneumonia. These data demonstrate the use of TF profiling in host AMs and Pneumocystis organism interactions that may lead to a better understanding of the specific inflammatory responses of the host to Pneumocystis pneumonia and may inform novel strategies for potential therapeutics.
Intracranial Stenting: Angioplasty Basic Technique, Indications, and Sizing: 2-Dimensional Operative Video
Dossani, Rimal H., Cappuzzo, Justin M. , Sonig, Ashish , Siddiqui, Adnan H. , Davies, Jason M. , Bain, Mark, Bendock, Bernard, Binning, Mandy J., Boulos, Alan S. , Crowley, Webster, Fessler, Richard D., Guterman, Lee R., Hoit, Daniel , Hopkins, L. Nelson , Howington, Jay U., James, Robert F. , Jankowitz, Brian T. , Kan, Peter , Khalessi, Alex A, Kim, Louis J. , Langer, David J. , Mack, William J. , Mericle, Robert A., Ogilvy, Chris, Replogle, Robert, Riina, Howard A. , Saugaveau, Eric, Schirmer, Clemens M. , Spiotta, Alex, Sultan, Ali, Turner, Raymond D , Veznedaroglu, Erol, Welch, Babu G. , Davies, Jason M , Siddiqui, Adnan H , Schirmer, Clemens M , Waqas, Muhammad , Levy, Elad I. , Arthur, Adam Stephen , Grande, Andrew Walker , Hanel, Ricardó A. , Kim, Louis J. , Lanzino, Giuseppe , Levitt, Michael R. , Lopes, Demetrius K. , Mocco, J , Pandey, Aditya S , Ringer, Andrew J. , Rodriguez, Rafael, Tawk, Rabih G. , Thomas, Ajith J , White, Jonathan Samuel

Mayo Clinic

Operative Neurosurgery | May 7, 2021 | Volume: 21 | Issue: 2 | Pages: E115-E116

10.1093/ons/opab124 | PMID 33956956 Get It

Abstract Intracranial atherosclerotic disease (ICAD) is a common cause of stroke. Antiplatelet therapy is the mainstay for symptomatic ICAD treatment. Endovascular management with submaximal angioplasty and/or intracranial stenting is reserved for patients with repeated ischemic events despite optimal medical therapy. We demonstrate intracranial angioplasty and stenting technique, technique indications, and sizing of stent and target vessel diameter. Stenting and angioplasty have been described in the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis and Wingspan Stent System Post Market Surveillance trials. 1,2 Submaximal angioplasty has also been described. 3 This patient, who had been on dual antiplatelet therapy for several months, initially presented with occlusion of the left middle cerebral artery M2 inferior division and underwent mechanical thrombectomy with successful reperfusion. Postoperatively, the patient's symptoms did not improve. Medical management was optimized with heparin infusion. However, repeat stroke study demonstrated M2 inferior division reocclusion. A decision was made to proceed with intracranial angioplasty and stenting. P2Y12 levels were therapeutic. Under moderate conscious sedation, submaximal angioplasty of up to 80% of the normal M2 caliber was attempted. However, we observed persistent high-grade stenosis of the M2 inferior division. The major risk of crossing the lesion for angioplasty is vessel perforation. To safely perform this maneuver, we used a J-configured Synchro-2 microwire (Stryker). Because of the patient's recent thrombectomy, we also had prior tactile feedback about how much resistance was encountered while crossing the occlusion. We then deployed a balloon-mounted intracranial stent for optimal radial force across the stenotic area to restore perfusion. Postoperative computed tomography perfusion showed resolution of the previously noticed perfusion deficit. The patient gave informed consent for the procedures and video recording. Institutional review board approval was deemed unnecessary. Video. ©University at Buffalo Neurosurgery, September 2020. With permission.
Common Femoral Artery Access: 2-Dimensional Operative Video
Darwal, Maureen A, Binning, Mandy J., Bain, Mark, Bendock, Bernard, Boulos, Alan S. , Fessler, Richard D., Guterman, Lee R., Hoit, Daniel , Hopkins, L. Nelson , Howington, Jay U., James, Robert F. , Jankowitz, Brian T. , Kan, Peter , Khalessi, Alex A, Kim, Louis J. , Langer, David J. , Mack, William J. , Mericle, Robert A., Ogilvy, Chris, Replogle, Robert, Riina, Howard A. , Saugaveau, Eric, Schirmer, Clemens M. , Spiotta, Alex, Turner, Raymond D , Welch, Babu G. , White, Jonathan A. , Schirmer, Clemens M , Grande, Andrew Walker , Hanel, Ricardó A. , Kim, Louis J. , Lanzino, Giuseppe , Levitt, Michael R. , Lopes, Demetrius K. , Mocco, J , Rodriguez, Rafael, Siddiqui, Adnan H. , Aziz‐Sultan, Mohammad Ali , Thomas, Ajith J

Mayo Clinic

Operative Neurosurgery | May 4, 2021 | Volume: 19 | Issue: 6 | Pages: E594-E594

10.1093/ons/opaa192 | PMID 34383930 Get It

Abstract Vascular access for cerebral angiography has traditionally been performed via the common femoral artery. It is crucial to obtain safe access to prevent complications that could lead to limb ischemia, groin hematoma, or retroperitoneal hematoma. This is especially true in neurointervention as many patients are anticoagulated or have received intravenous thrombolytics prior to their intervention. Special attention to anatomic landmarks, both grossly and radiographically, can help to assure safe access. The patient consented for this procedure. This video details rapid but safe femoral artery access in a patient undergoing emergent thrombectomy.
Targeting Aging-Induced PIM1 Kinase in Lung Fibroblasts to Promote Fibrosis Resolution
Pham, Tho X., Guan, Jiahui , Meridew, Jeffrey A., Choi, Kyoung Moo , Haak, Andrew J. , Huang, S.K., Tschumperlin, Daniel J. , Ligresti, Giovanni , Lee, Jeffrey D. , Guan, J., Caporarello, Nunzia , Jones, Dakota L. , Tan, Qi

Mayo Clinic

TP116. TP116 PRECLINICAL THERAPEUTIC MODELS OF FIBROSIS | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A4440-A4440

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4440 Get It

Endobronchial Optical Coherence Tomography: A Novel Method for the Microscopic Diagnosis of Usual Interstitial Pneumonia and Idiopathic Pulmonary Fibrosis
Raphaely, Rebecca A., Nandy, Sreyankar , Muniappan, Ashok , Shih, A., Roop, Benjamin W., Sharma, Ankur , Keyes, Colleen , Colby, T.V., Auchincloss, Hugh, Gaissert, Henning A. , Morse, Christopher R., Ott, Harald C. , Wain, Jonn C., Wright, C.D., Liang, Lichen , Davies, Diane, Adams, David C. , Szabari, Margit V., Tager, Andrew M. , Suter, Melissa J., Colby, T V, Lanuti, Michael D. , Mino-Kenudson, Mari A. , Horick, Nora , Caravan, Peter D. , Medoff, Benjamin D. , Hariri, Lida P.

Mayo Clinic

TP26. TP026 DIAGNOSIS, ASSESSMENT, AND PROGNOSIS OF FIBROTIC ILD | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A1853-A1853

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1853 Get It

Smoking Cessation Interventions in Native Americans, a Systematic Review
Rusk, A., Kanj, A., Murad, H., Kennedy, C.C., Rusk, Andrew, Kanj, A.N., Hassett, Leslie C.

Mayo Clinic

TP16. TP016 CLINICAL AND RESEARCH UPDATES ON TOBACCO CESSATION, VAPING, AND E-CIGARETTES | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A1651-A1651

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1651 Get It

Challenges in Diagnosis and Management of Hemobilia
Parvinian, Ahmad , Fletcher, Joel G. , Venkatesh, Sudhakar K. , Fidler, Jeff L. , Khandelwal, Ashish , Storm, Andrew C , Venkatesh, Sudhakar K , Fidler, Jeff L. , Khandelwal, Ashish R , Fletcher, Joel G , Storm, Andrew C.

Mayo Clinic

RadioGraphics | May 3, 2021 | Volume: 41 | Issue: 3 | Pages: 802-813

10.1148/rg.2021200192 | PMID 33939540 Get It